Therapeutic potential of AAV-mediated MMP-3 secretion from corneal endothelium in treating glaucoma
Year: 2017
Type: article
Abstract: Intraocular pressure (IOP) is maintained as a result of the balance between production of aqueous humour (AH) by the ciliary processes and hydrodynamic resistance to its outflow through the conventional outflow pathway comprising the trabecular meshwork (TM) and Schlemm's canal (SC). Elevated IOP, which can be caused by increased resistance to AH outflow, is a major risk factor for open-angle glaucoma. Matrix metalloproteinases (MMPs) contribute to conventional aqueous outflow homeostasis in their capacity to remodel extracellular matrices, which has a direct impact on aqueous outflow resistance and IOP. We observed decreased MMP-3 activity in human glaucomatous AH compared to age-matched normotensive control AH. Treatment with glaucomatous AH resulted in significantly increased transendothelial resistance of SC endothelial and TM cell monolayers and reduced monolayer permeability when compared to control AH, or supplemented treatment with exogenous MMP-3.Intracameral inoculation of AAV-2/9 containing a CMV-driven MMP-3 gene (AAV-MMP-3) into wild type mice resulted in efficient transduction of corneal endothelium and an increase in aqueous concentration and activity of MMP-3. Most importantly, AAV-mediated expression of MMP-3 increased outflow facility and decreased IOP, and controlled expression using an inducible promoter activated by topical administration of doxycycline achieved the same effect. Ultrastructural analysis of MMP-3 treated matrices by transmission electron microscopy revealed remodelling and degradation of core extracellular matrix components. These results indicate that periodic induction, via use of an eye drop, of AAV-mediated secretion of MMP-3 into AH could have therapeutic potential for those cases of glaucoma that are sub-optimally responsive to conventional pressure-reducing medications.
Source: Human Molecular Genetics
DOI: 10.1093/hmg/ddx028
Authors: Jeffrey O’Callaghan, Darragh. E. Crosbie, Paul. S. Cassidy, Joseph M. Sherwood, Cassandra Flügel-Koch, Elke Lütjen-Drecoll, Marian M. Humphries, Ester Reina-Torres, Deborah Wallace, Anna-Sophia Kiang, Matthew Campbell, W. Daniel Stamer, Darryl R. Overby, Colm O’Brien, Lawrence C. S. Tam, Peter Humphries
Language: English
Subfield: Ophthalmology
Field: Medicine
Domain: Health Sciences
Keywords: glaucoma, MMP-3, matrix metalloproteinases, adeno-associated virus gene therapy, corneal endothelium, aqueous humor outflow, intraocular pressure, Schlemm's canal, trabecular meshwork, extracellular matrix remodeling, doxycycline-inducible expression, topical gene therapy, open-angle glaucoma
Open Access status: hybrid
Estimated APC paid: $4,390
Awards: The Mechanical Basis of Primary Open Angle Glaucoma, A radical approach for improved glaucoma treatment, SFI ERC Support - Pete Humphries, A Biomimetic Microfluidics Platform for High-Throughput Screening of Endothelial Barrier Dysfunction, with Applications to Atherosclerosis, eNOS-Dependent Mechanoregulation of Intraocular Pressure
OpenAlex ID: W2585780878
